Agebox Milestones
2009
Established the first biological laboratory in Charleston, South Carolina, initiating research in the field of cellular biology.
2010
Launched the Xpes (Xregen Precision Extraction System) technology platform. This platform enables precise secondary extraction of natural materials certified by the GRAS system, combined with cell biology techniques, completing the development platform for Agebox's functional dietary supplements.
2011
Successfully developed the anti-aging product S-NAD(+). Utilizing multiple advanced extraction techniques, the Agebox scientific team perfected a method for extracting natural compounds, leading to the creation of an anti-aging product targeting coenzyme NAD(+).
2012
Agebox's Chief Scientist was awarded the title of Fellow of the American Institute for Medical and Biological Engineering. The laboratory was relocated to Richmond, Virginia.
2013
Successfully developed the SenolyAct key technology.
2016
Completed the Xpes cell pathway and molecular target map. Using the Xpes technology platform, the Agebox scientific team identified nearly a thousand high-potency natural extracts with clear targets, mapping 17 core signaling pathways across eight systems, including bone and muscle development, lipid, blood glucose, uric acid metabolism, and neuroinflammation, covering 62 key molecular targets.
2018
Launched multiple high-efficacy dietary supplements for children's health, gynecology, and elderly care. Based on the cell pathway and molecular target map and extensive cell and animal experiment data, Agebox scientists developed functional dietary supplement formulations for conditions such as autism, depression, ADHD, metabolic syndrome, and dry eye syndrome.
2021
Completed the development of a functional dietary supplement for children with growth and developmental delays after five years of research. The same year, Agebox's Chinese laboratory, Xregen Lab, was officially established.
2022
Founded Regenerative Health Technology (Hangzhou) Co., Ltd.
2023
Secured 30 million RMB in angel round financing and initiated an IIT clinical study with Zhejiang Children's Hospital on the intervention of SRS (Silver-Russell Syndrome) with iKids-Growth.